As Teva's Neurology Portfolio Gains Momentum, New Assets Join The Pipeline

 
• By Jessica Merrill

Q3 results show Austedo appears headed towards blockbuster status, and the company signed a collaboration with MODAG for two compounds for neurodegenerative diseases.

ripples in a pond
Teva looks to build out in neuroscience • Source: Alamy

More from Neurological

More from Therapy Areas